⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
EcoVadis Study: 72% of US Executives Say Tariffs & Trade Wars Are Top Supply Chain Risk to Business
businesswire.com
JNJ
LRLCY
UL
BRDG
BASFY
JPM
Genexa, the First-Ever Clean Medicine Brand, Releases State of the Sick Day Study, Revealing What Parents Actually Face When Their Kids Get Sick
businesswire.com
JNJ
COVID-19 Diagnostic Research Report 2025: 5 Year Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides - ResearchAndMarkets.com
businesswire.com
ABT
AMGN
BDX
BIO
CERN
DGX
DHR
ENZ
EXAS
GILD
HHC
HOLX
ILMN
ISRG
JNJ
LH
LMT
MRNA
MYL
NBIX
NOC
NTRA
NVTA
ONVO
ORCL
PDD
PFE
QGEN
QRVO
REGN
RHHBY
RMD
ROST
SGEN
SIGA
SNPS
SPLK
SRPT
STEM
SYK
TCOM
TGT
TMO
TSLA
TXG
VRTX
WBA
XRAY
Immunoassay Market Research, Strategies, Trends and Forecasts Report 2025 with Executive Guides and Impact of Artificial Intelligence - ResearchAndMarkets.com
businesswire.com
ALGN
AMZN
BDX
BIO
BMY
CDNS
CERN
CHKP
CLVS
CODX
CRSP
CYTK
DELL
DGX
DHR
DIS
DTC
DXCM
ENZ
EXAS
FSLR
GILD
GOOG
IDXX
ILMN
INCY
INTC
ISRG
JNJ
LULU
LUMX
MDLZ
MRNA
MSFT
MYL
NBIX
NCLH
NFLX
NVS
NVTA
ORCL
ORGO
OSIP
OTIS
PANW
PFE
PG
PGR
PPC
PRGO
QCOM
QGEN
QORV
QUID
REGN
ROCH
ROST
SGEN
SIRI
SNPS
SPLK
SRPT
SWKS
SYK
TCOM
TEAM
TEVA
TGT
TMO
TSLA
TXN
ULTA
UNH
VRTX
WBA
WDC
WEC
WFC
XRAY
XTRA
ZBRA
Executive From Wegmans Food Markets Joins GS1 US Board of Governors
prnewswire.com
BJS
KSS
AMZN
KO
JNJ
K
PEP
PG
PSB
PVH
SYY
TGT
WMT
New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis
prnewswire.com
JNJ
DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
prnewswire.com
JNJ
FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder
prnewswire.com
JNJ
Johnson & Johnson to Participate in the Citi’s 2025 Global Healthcare Conference
businesswire.com
JNJ
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
prnewswire.com
IOVA
MRK
LLY
JNJ